Anika Therapeutics Stock
Price
Target price
?
?
-3.250%
-0.4
-3.250%
€13.51
08:05 / Frankfurt
WKN: 889120 / Symbol: ANIK / Name: Anika / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Anika Therapeutics Stock
Heavy losses for Anika Therapeutics today as the stock fell by -€0.400 (-3.250%).
Currently there is a rather positive sentiment for Anika Therapeutics with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 13 € shows a slightly positive potential of 9.24% compared to the current price of 11.9 € for Anika Therapeutics.
For the coming years our community has positive and negative things to say abot the Anika Therapeutics stock. Criterium "Brand" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Anika Therapeutics in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Anika Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Anika Therapeutics | -3.250% | -0.806% | -2.381% | 26.804% | 53.750% | -50.403% | -67.969% |
| Heron Therapeutics Inc. | 7.600% | -50.806% | -66.818% | -80.098% | -67.145% | -65.143% | -96.715% |
| Evolus Inc | -2.000% | 2.559% | 6.592% | -31.006% | 4.440% | -29.292% | -36.402% |
| Rhythm Pharmaceuticals | -1.330% | -1.316% | -8.537% | 31.579% | -19.786% | 374.684% | 393.421% |
Comments
Anika Therapeutics (ANIK) had its price target raised by Barrington Research from $16.00 to $17.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (NASDAQ:ANIK) had its price target raised by analysts at Barrington Research from $15.00 to $16.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $15.00 price target on the stock.
Show more
Ratings data for ANIK provided by MarketBeat